SuperworthApimeds Pharmaceuticals US shares outstanding APUS
Diluted shares outstanding, averaged over each quarter, from 2024.
- Latest quarter, to Jun 30, 2026
- 1.7M
- On a year earlier
- +65.2%
- more shares
Apimeds Pharmaceuticals US had 1.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 65.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 1.3M | +1492% |
| FY2024 | 79K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 1.7M | +65% | |
| Q1 FY26 | 1.6M | +1863% | |
| Q4 FY25 | 1.3M | +1492% | |
| Q3 FY25 | 125.8K | +59% | |
| Q2 FY25 | 1M | +1212% | |
| Q1 FY25 | 79K | +0% | |
| Q4 FY24 | 79K | n/a | |
| Q3 FY24 | 79K | n/a | |
| Q2 FY24 | 79K | n/a | |
| Q1 FY24 | 79K | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Apimeds Pharmaceuticals US
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.